Neuronetics, Inc.
STIM
$4.48
$0.245.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.49M | 18.53M | 16.45M | 17.42M | 20.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.49M | 18.53M | 16.45M | 17.42M | 20.31M |
| Cost of Revenue | 7.00M | 4.53M | 4.27M | 4.33M | 2.64M |
| Gross Profit | 15.49M | 14.00M | 12.18M | 13.09M | 17.67M |
| SG&A Expenses | 20.59M | 19.31M | 18.45M | 17.60M | 17.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.37M | 26.26M | 24.96M | 24.28M | 22.84M |
| Operating Income | -10.87M | -7.73M | -8.51M | -6.86M | -2.53M |
| Income Before Tax | -12.68M | -13.34M | -9.83M | -7.87M | -5.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.68M | -13.34M | -9.83M | -7.87M | -5.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 19.00K | -- | -- | -- | -- |
| Net Income | -12.66M | -13.34M | -9.83M | -7.87M | -5.38M |
| EBIT | -10.87M | -7.73M | -8.51M | -6.86M | -2.53M |
| EBITDA | -10.52M | -7.17M | -8.00M | -6.30M | -2.11M |
| EPS Basic | -0.35 | -0.44 | -0.33 | -0.27 | -0.19 |
| Normalized Basic EPS | -0.25 | -0.18 | -0.20 | -0.17 | -0.07 |
| EPS Diluted | -0.35 | -0.44 | -0.33 | -0.27 | -0.19 |
| Normalized Diluted EPS | -0.25 | -0.18 | -0.20 | -0.17 | -0.07 |
| Average Basic Shares Outstanding | 36.67M | 30.27M | 30.05M | 29.47M | 29.05M |
| Average Diluted Shares Outstanding | 36.67M | 30.27M | 30.05M | 29.47M | 29.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |